Last updated 7 months ago

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

700 patients around the world
Available in Argentina, Mexico, United States, Colombia, Spain
Bristol-Myers Squibb
20Research sites
700Patients around the world
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Instituto Médico de Alta Complejidad San Isidro IMACSI
Instituto Médico de Alta Complejidad San Isidro IMACSI
Recruiting
Av. del Libertador 16958, San Isidro, Buenos Aires
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Recruiting
Av. Luis Maria Campos 726, CABA, Buenos Aires
Centro de Investigaciones Reumatológicas
Recruiting
Las Piedras 108, San Miguel de Tucumán
Fundación Santa Fe de Bogotá
Recruiting
calle 119 #7 75, Bogotá
SERVIMED S.A.S.
Recruiting
Calle 51 No 34-17 Consultorio 208 - Bucaramanga
Healthy Medical Center
Recruiting
Cra. 4 # 7-39, Zipaquirá, Cundinamarca
Centro Integral de Reumatología del Caribe Circaribe SAS
Recruiting
Cl. 71 #41 - 46, Nte. Centro Histórico, Barranquilla, Atlántico
Uniendo Centro de Investigación - Solano y Terront Servicios Médicos Ltda.
Recruiting
Carrera 16 # 80-33, Bogotá
Hospital Pablo Tobón Uribe
Recruiting
CL 78B #69 - 240, Cordoba, Medellín, Robledo, Medellín, Antioquia, Colombia
Centro de Investigación Médico Asistencial S.A.S. - CIMEDICAL S.A.S.
Recruiting
Cra 49c N 82 - 120 - Barranquilla
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy